CD44 and pancreatic neoplasm: To understand the biological role of miR-629 in pancreatic cancer progression, miR-629 mimic was transduced into the Capan-2 pancreatic cancer cell line, and we found that miR-629 overexpression significantly increased the population of CD44+CD24+ESA+ cells compared with the control cells (Figure 4a).